08/07/2026
A common misconception about clinical trials is that success begins when the first participant is enrolled.
In reality, many of the decisions that determine whether a study succeeds happen months before recruitment even starts.
Before a research site opens its doors to participants, the teams have already spent weeks or even months planning how the study will run.
The protocol has been developed, potential research sites have been evaluated, regulatory and ethics submissions have been prepared, and investigators have assessed whether the study is actually feasible at their site.
These early decisions influence almost everything that follows.
When planning is rushed, or feasibility is poorly assessed, studies are more likely to experience recruitment delays, protocol deviations, data quality issues, and costly amendments.
Planning is not simply an administrative phase; it is one of the most important stages of the clinical trial lifecycle.
Good planning creates the conditions for quality. It helps research teams execute the protocol consistently, protects participant safety, strengthens data integrity, and gives sponsors greater confidence in the results.
As more sponsors look toward Nigeria and West Africa for clinical research, investing in robust study planning and operational readiness is essential for successful trial delivery.
At UCTSS, we support sponsors, CROs, and research sites across West Africa with feasibility assessments, regulatory affairs, clinical trial operations, data management, pharmacovigilance, and digital trial oversight through our United Clinical Trial Management System (UCTMS).
If West Africa is part of your clinical development strategy, we'd be happy to start a conversation.
📩 [email protected]
🌐 unitedclinicalss.com
